G1 Therapeutics News

G1 Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Apr 9 16:31 ET

G1 Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Feb 12 16:46 ET

G1 Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Jan 9 00:00 ET

G1 Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Dec 12, 2023 16:40 ET

G1 Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Dec 11, 2023 18:43 ET

G1 Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Aug 8, 2023 19:28 ET

G1 Therapeutics | 424B5: Prospectus

Nov 18, 2022 19:37 ET

G1 Therapeutics | 424B5: Prospectus

Nov 17, 2022 16:04 ET

G1 Therapeutics | EFFECT: Others

May 4, 2022 00:15 ET

G1 Therapeutics | 424B5: Prospectus

Sep 19, 2018 16:58 ET

G1 Therapeutics | 424B5: Prospectus

Sep 17, 2018 17:30 ET

G1 Therapeutics | 424B4: Prospectus

Mar 8, 2018 16:50 ET

G1 Therapeutics | EFFECT: Others

Mar 8, 2018 00:15 ET

G1 Therapeutics | 424B4: Prospectus

May 17, 2017 17:28 ET

G1 Therapeutics | EFFECT: Others

May 17, 2017 00:15 ET

G1 Therapeutics | 8-A12B: Registration of a class of securities on a national securities exchange

May 15, 2017 17:41 ET